Human TRAILR4/TNFRSF10D PE-conjugated Antibody | R&D Systems FAB633P product information

product summary

company name :

R&D Systems

product type :

antibody

product name :

Human TRAILR4/TNFRSF10D PE-conjugated Antibody

catalog :

FAB633P

quantity :

100 Tests

price :

439 USD

clonality :

monoclonal

host :

mouse

conjugate :

clone name :

104918

reactivity :

human

application :

flow cytometry

more info or order :

R&D Systems product webpage

citations: 20

Published Application/Species/Sample/Dilution	Reference
flow cytometry; human; fig st1	Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
flow cytometry; human	Kim S, Woo J, Jeong C, Ryu C, Jang J, Jeun S. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Stem Cells Transl Med. 2014;3:172-82 pubmed publisher
flow cytometry; human	Kalb M, Glaser A, Stary G, Koszik F, Stingl G. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-?-mediated antitumor reactivity. J Immunol. 2012;188:1583-91 pubmed publisher
flow cytometry; human	Stary G, Klein I, Kohlhofer S, Koszik F, Scherzer T, Müllauer L, et al. Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood. 2009;114:3854-63 pubmed publisher
flow cytometry; human	Secchiero P, Melloni E, Corallini F, Beltrami A, Alviano F, Milani D, et al. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells. 2008;26:2955-63 pubmed publisher
flow cytometry; human	Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy P, Lampertico P, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med. 2007;204:667-80 pubmed
	Greenlee J, Lopez Cavestany M, Ortiz Otero N, Liu K, Subramanian T, Cagir B, et al. Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization. elife. 2021;10: pubmed publisher
	Ren Y, Wang X, Huang S, Xu Y, Weng G, Yu R. Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis. Front Pharmacol. 2021;12:560903 pubmed publisher
	Madsen S, Jones S, Tucker H, Giler M, Muller D, Discher C, et al. Survival of aging CD264+ and CD264- populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency. Biotechnol Bioeng. 2020;117:223-237 pubmed publisher
	Jo E, Lee Y, Lee H, Park J, Park H, Choi Y, et al. Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells. BMC Cancer. 2019;19:496 pubmed publisher
	Madsen S, Russell K, Tucker H, Glowacki J, Bunnell B, O Connor K. Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2017;8:201 pubmed publisher
	Jaworska D, Szliszka E. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells. Int J Mol Sci. 2017;18: pubmed publisher
	Singh H, Otano I, Rombouts K, Singh K, Peppa D, Gill U, et al. TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis. Sci Rep. 2017;7:5514 pubmed publisher
	Zauli G, Celeghini C, Monasta L, Martinelli M, Luppi S, Gonelli A, et al. Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. Reproduction. 2014;148:191-8 pubmed publisher
	Tang X, Lu J, Tu H, Huang K, Fu R, Cao G, et al. TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells. Anticancer Res. 2014;34:729-34 pubmed
	Trebing J, El Mesery M, Schafer V, Weisenberger D, Siegmund D, Silence K, et al. CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants. Cell Death Dis. 2014;5:e1035 pubmed publisher
	Walsh C, Luer C, Yordy J, Cantu T, Miedema J, Leggett S, et al. Epigonal conditioned media from bonnethead shark, Sphyrna tiburo, induces apoptosis in a T-cell leukemia cell line, Jurkat E6-1. Mar Drugs. 2013;11:3224-57 pubmed publisher
	Gojo I, Tan M, Fang H, Sadowska M, Lapidus R, Baer M, et al. Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia. Clin Cancer Res. 2013;19:1838-51 pubmed publisher
	Zhang B, Shan H, Li D, Li Z, Zhu K, Jiang Z, et al. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5. Oncol Rep. 2011;25:461-8 pubmed publisher
	Kim S, Lim J, Park S, Jeong C, Oh J, Jeong M, et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008;68:9614-23 pubmed publisher

product information

master code :

FAB633P

SKU :

FAB633P

product name :

Human TRAILR4/TNFRSF10D PE-conjugated Antibody

unit size :

100 Tests

description :

The Human TRAILR4/TNFRSF10D PE-conjugated Antibody from R&D Systems is a mouse monoclonal antibody to TRAILR4/TNFRSF10D/DcR2. This antibody reacts with human,rat. The Human TRAILR4/TNFRSF10D PE-conjugated Antibody has been validated for the following applications: Flow Cytometry.

target :

TRAILR4/TNFRSF10D

category :

Primary Antibodies

buffer :

Supplied in a saline solution containing BSA and Sodium Azide.

clonality :

Monoclonal

clone :

104918

conjugate :

Phycoerythrin

host :

Mouse

immunogen :

Mouse myeloma cell line NS0-derived recombinant human TRAIL R4/TNFRSF10D, Ala56-His211, Accession # Q9UBN6

isotype :

IgG1

purity :

Protein A or G purified from ascites

species :

Human,Rat

specificity :

Detects human TRAIL R4/TNFRSF10D in ELISAs and Western blots. In sandwich immunoassays, less than 5% cross-reactivity with recombinant human (rh) TRAIL R1, rhTRAIL R2, TRAIL R3, rhTRAIL, rhTNF-alpha , and rhTNF┐▀ is observed.

gene symbol :

TNFRSF10D

top caption :

Detection of TRAIL R4/TNFRSF10D antibody in Human Blood Granulocytes antibody by Flow Cytometry.

accessionNumbers :

Q9UBN6

applications :

Flow Cytometry

USD :

439 USD

alt names :

CD264, CD264 antigen, DcR2, DCR2decoy with truncated death domain, Decoy receptor 2, TNF receptor-related receptor for TRAIL, TNF-related apoptosis-inducing ligand receptor 4, TNFRSF10D, TRAIL R4, TRAIL-R4, TRAILR4TRAIL receptor 4, TRUNDDTRAIL receptor with a truncated death domain, tumor necrosis factor receptor superfamily member 10D, tumor necrosis factor receptor superfamily, member 10d, decoy with truncateddeath domain

storage :

Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 ░C as supplied.

more info or order :

R&D Systems product webpage